ECE2021 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (82 abstracts)
Hospital Universitario Central de Asturias, Spain; 2Grupo ENDO, Instituto de Investigación Sanitaria del Principado de Asturias ISPA, Spain
Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has generate a pandemic disease around the world. It has been documented that diabetes mellitus (DM) acts as a risk factor among people hospitalized with coronavirus disease (COVID-19). The objective of this study is to test if DM may unfavorably influence the outcome of COVID-19.
Methods
Data from Hospital Universitario Central de Asturias (Spain) of patients older than 55 years hospitalized with COVID-19 between 3 March 2020 and 30 September 2020 were collected. We compared patients with previous diagnoses of type 2 DM and no diabetes patients. We analyzed the percentage of deaths according to glycosylated hemoglobin (HbA1c) in the last 365 days before admission. Analysis was performed by using GraphPad Prism, 8.0.1 version. Statistical differences were evaluated by Chi-square and Chi-square with Yates correction.
Results
TSH(Iu/ml) | Tg (ng/ml) | Anti-Tg (u/ml) | Tg washout | |
Post-ablation WBS | 73 | 27.3 | 19 | |
Diagnostic WBS | 41.4 | 25.5 | 18 | |
Left level IV (8.5 Χ 8.7 Χ 11 mm) |
4 | 0.89 | ||
Left level IV (7.7 Χ 9.4 Χ 10.8 mm) |
4 | 0.3 |
Discussion
Our results suggest that diabetes mellitus could be a risk factor of death in patients hospitalized with COVID-19, even if there is no statistical association. According to our study, an innapropiate glycemic control could increase the risk of death. It is necessary to perform new researches to confirm these results. In conclusion, COVID-19 is a new reason to encourage our patients to achieve therapeutic goals.